Improving lung health in low-income and middle-income countries: from challenges to solutions
Low-income and middle-income countries (LMICs) bear a disproportionately high burden of
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
the global morbidity and mortality caused by chronic respiratory diseases (CRDs), including …
Subclinical tuberculosis disease—a review and analysis of prevalence surveys to inform definitions, burden, associations, and screening methodology
B Frascella, AS Richards, B Sossen… - Clinical Infectious …, 2021 - academic.oup.com
While it is known that a substantial proportion of individuals with tuberculosis disease (TB)
present subclinically, usually defined as bacteriologically-confirmed but negative on …
present subclinically, usually defined as bacteriologically-confirmed but negative on …
Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection
Tuberculosis (TB) is the leading infectious cause of mortality worldwide, due in part to a
limited understanding of its clinical pathogenic spectrum of infection and disease …
limited understanding of its clinical pathogenic spectrum of infection and disease …
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
JS Zifodya, I Schiller, N Dendukuri… - Cochrane Database …, 2019 - cochranelibrary.com
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …
newest version, are the only World Health Organization (WHO)‐recommended rapid tests …
New developments in tuberculosis diagnosis and treatment
CM Gill, L Dolan, LM Piggott, AM McLaughlin - Breathe, 2022 - Eur Respiratory Soc
Tuberculosis (TB) is a major cause of morbidity and mortality worldwide. It is estimated that
25% of the world's population are infected with Mycobacterium tuberculosis, with a 5–10 …
25% of the world's population are infected with Mycobacterium tuberculosis, with a 5–10 …
Tuberculosis: advances and challenges in development of new diagnostics and biomarkers
Tuberculosis remains the leading cause of death from an infectious disease worldwide.
Early and accurate diagnosis and detection of drug-sensitive and drug-resistant tuberculosis …
Early and accurate diagnosis and detection of drug-sensitive and drug-resistant tuberculosis …
[HTML][HTML] Emergence of a novel coronavirus causing respiratory illness from Wuhan, China
In previous reports, workers have characterized the presentation of Middle East Respiratory
Syndrome (MERS) 1 and Severe Acute Respiratory Syndrome (SARS) 2 to aid clinical …
Syndrome (MERS) 1 and Severe Acute Respiratory Syndrome (SARS) 2 to aid clinical …
Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
M Kohli, I Schiller, N Dendukuri… - Cochrane Database …, 2018 - cochranelibrary.com
Background Tuberculosis (TB) is the world's leading infectious cause of death.
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
Background Every year, an estimated one million children and young adolescents become
ill with tuberculosis, and around 226,000 of those children die. Xpert MTB/RIF Ultra (Xpert …
ill with tuberculosis, and around 226,000 of those children die. Xpert MTB/RIF Ultra (Xpert …
The epidemiological importance of subclinical tuberculosis. A critical reappraisal
From Chlamydia (1) to malaria (2) to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)(3), it is increasingly recognized that individuals without recognizable …
(SARS-CoV-2)(3), it is increasingly recognized that individuals without recognizable …